Literature DB >> 11953353

Management of reflux disease.

J Dent1.   

Abstract

The management of reflux disease can be divided into three major phases, the first being diagnosis and severity assessment, the second, prompt initial control of symptoms, and the third, selection of a long term management approach that is tailored to meet individual patient needs and preferences. Throughout these phases of management, the major priorities should include achieving patient satisfaction and minimising management costs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11953353      PMCID: PMC1867689          DOI: 10.1136/gut.50.suppl_4.iv67

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  19 in total

1.  Gastro-oesophageal reflux disease in primary care: an international study of different treatment strategies with omeprazole. International GORD Study Group.

Authors:  R Carlsson; J Dent; R Watts; S Riley; R Sheikh; J Hatlebakk; K Haug; G de Groot; A van Oudvorst; A Dalväg; O Junghard; I Wiklund
Journal:  Eur J Gastroenterol Hepatol       Date:  1998-02       Impact factor: 2.566

2.  Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta-analysis of long-term omeprazole trials.

Authors:  R Carlsson; J P Galmiche; J Dent; L Lundell; L Frison
Journal:  Aliment Pharmacol Ther       Date:  1997-06       Impact factor: 8.171

3.  Treating the symptoms of gastro-oesophageal reflux disease: a double-blind comparison of omeprazole and cisapride.

Authors:  J P Galmiche; P Barthelemy; B Hamelin
Journal:  Aliment Pharmacol Ther       Date:  1997-08       Impact factor: 8.171

4.  Third generation cephalosporins in the parenteral to oral switch.

Authors:  D Rimmer
Journal:  Pharmacoeconomics       Date:  1994       Impact factor: 4.981

5.  Speed of healing and symptom relief in grade II to IV gastroesophageal reflux disease: a meta-analysis.

Authors:  N Chiba; C J De Gara; J M Wilkinson; R H Hunt
Journal:  Gastroenterology       Date:  1997-06       Impact factor: 22.682

6.  Laparoscopic surgery for gastro-oesophageal reflux: beyond the learning curve.

Authors:  D I Watson; G G Jamieson; R J Baigrie; G Mathew; P G Devitt; P A Game; R Britten-Jones
Journal:  Br J Surg       Date:  1996-09       Impact factor: 6.939

7.  Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis.

Authors:  R H Holloway; J Dent; F Narielvala; A M Mackinnon
Journal:  Gut       Date:  1996-05       Impact factor: 23.059

8.  Natural course of gastroesophageal reflux disease: 17-22 year follow-up of 60 patients.

Authors:  J Isolauri; M Luostarinen; E Isolauri; P Reinikainen; M Viljakka; O Keyriläinen
Journal:  Am J Gastroenterol       Date:  1997-01       Impact factor: 10.864

Review 9.  Gastro-oesophageal reflux disease.

Authors:  J Dent
Journal:  Digestion       Date:  1998-08       Impact factor: 3.216

10.  Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

Authors:  E C Klinkenberg-Knol; H P Festen; J B Jansen; C B Lamers; F Nelis; P Snel; A Lückers; C P Dekkers; N Havu; S G Meuwissen
Journal:  Ann Intern Med       Date:  1994-08-01       Impact factor: 25.391

View more
  2 in total

Review 1.  Treatment of uncomplicated reflux disease.

Authors:  Joachim Labenz; Peter Malfertheiner
Journal:  World J Gastroenterol       Date:  2005-07-28       Impact factor: 5.742

Review 2.  Gastroesophageal Reflux Disease (GERD): Highlighting Diagnosis, Treatment, and Lifestyle Changes.

Authors:  Pratyaksh Chhabra; Nishikant Ingole
Journal:  Cureus       Date:  2022-08-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.